The Department of Health and Human Services (HHS) has released a set of 26 quality measures that will eventually be used to determine the quality of care that adult Medicaid patients are receiving in each state.
The Affordable Care Act (ACA) required HHS to publish a core set of health quality measures for Medicaid-eligible adults by Jan. 1, 2012.
After numerous meetings with representatives from the Centers for Medicare and Medicaid Services and the Agency for Healthcare Research and Quality, HHS pinpointed 51 quality measures. But after it received comments that 51 was too many, it narrowed the list to 26.
The final list, which was published in the Federal Register on Jan. 4.
Read more at: http://tinyurl.com/83uehee
Source: MedPage Today
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More
Risk for Second Primary Melanoma Increases After Primary Melanoma Diagnosis as Men Age
March 28th 2024A population-based cohort study out of Norway has found that older men have a higher risk of developing second primary invasive melanoma following an initial primary melanoma, suggesting the benefits of increased surveillance in these patients.
Read More